Improved Anticancer Effect of Recombinant Protein izTRAIL Combined with Sorafenib and Peptide iRGD

Roman Fadeev1,2, Alexey Chekanov3,4, Marina Solovieva5

  • 1Institute of Theoretical and Experimental Biophysics, Russian Academy of Sciences, Pushchino, Moscow Region 142290, Russia. fadeevrs@gmail.com.

Insights

Multicellular resistance hinders cancer drug effectiveness. Combining TRAIL (TNFα-related apoptosis inducing ligand) with sorafenib and iRGD peptide overcomes this resistance, significantly improving anticancer effects in vivo.

Area of Science:

  • Oncology
  • Molecular Biology
  • Drug Development

Background:

  • Developing cancer drugs that selectively kill tumor cells without harming normal cells is a major challenge.
  • Overcoming cancer cell drug resistance and ensuring effective drug delivery to tumors are critical unmet needs in oncology.
  • Recombinant TRAIL (TNFα-related apoptosis inducing ligand) protein shows promise as a selective anticancer agent, but its in vivo efficacy is limited by multicellular resistance.

Purpose of the Study:

  • To investigate if combining the recombinant TRAIL protein with sorafenib and the tumor-penetrating peptide iRGD can overcome multicellular TRAIL resistance and enhance anticancer effects in vivo.
  • To evaluate the efficacy of sorafenib in suppressing multicellular TRAIL resistance in cancer cells.
  • To assess the combined effect of sorafenib and iRGD on the therapeutic potential of TRAIL against human fibrosarcoma xenografts.

Main Methods:

  • Assessing the development of TRAIL resistance in human fibrosarcoma HT-1080 cells in confluent cultures and spheroids.
  • Evaluating the ability of sorafenib at non-toxic concentrations to inhibit multicellular TRAIL resistance in vitro.
  • Testing the combined efficacy of recombinant TRAIL (izTRAIL) with sorafenib and iRGD in a mouse model of human fibrosarcoma HT-1080 grafts.

Main Results:

  • Human fibrosarcoma HT-1080 cells exhibited increased resistance to izTRAIL in confluent cultures and spheroids.
  • Sorafenib effectively suppressed TRAIL resistance mediated by confluent or spheroid cancer cells in vitro.
  • The combination of sorafenib and iRGD significantly enhanced the anticancer effect of izTRAIL in HT-1080 fibrosarcoma tumors in mice.

Conclusions:

  • Multicellular resistance is a key factor contributing to the inefficacy of TRAIL alone in vivo.
  • Sorafenib can effectively inhibit multicellular TRAIL resistance.
  • Combining TRAIL with sorafenib and the tumor-penetrating peptide iRGD represents a promising strategy to improve the in vivo anticancer efficacy of TRAIL.

Related Concept Videos

Recombinant DNA01:09

Recombinant DNA

Overview
102.6K
Peptide Bonds02:43

Peptide Bonds

A peptide bond covalently attaches amino acids through a dehydration reaction. One amino acid's carboxyl group and another amino acid's amino group combine, releasing a water molecule. The resulting bond is the peptide bond. The products that such linkages form are peptides. As more amino acids join this growing chain, the resulting chain is a polypeptide. Each polypeptide has a free amino group at one end. This end has the N-terminal, or the amino-terminal, and the other end has a free...
82.8K
Homologous Recombination02:31

Homologous Recombination

The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
62.9K
Viral Recombination00:57

Viral Recombination

Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
25.1K
Conservative Site-specific Recombination and Phase Variation02:53

Conservative Site-specific Recombination and Phase Variation

Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
6.8K
Overview of Transposition and Recombination02:13

Overview of Transposition and Recombination

Transposons make up a significant part of genomes of various organisms. Therefore, it is believed that transposition played a major evolutionary role in speciation by changing genome sizes and modifying gene expression patterns. For example, in bacteria, transposition can lead to conferring antibiotic resistance. Movement of transposable elements within the genetic pool of pathogenic bacteria can aid in transfer of antibiotic-resistant genetic elements. In eukaryotes, transposons can carry out...
19.2K